Allegra Franchise Adds Pediatric Oral Suspension
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi-Aventis’ allergic rhinitis therapy is approved for seasonal allergies and idiopathic urticaria in children as young as 6 months.